UK markets closed

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
87.28+1.16 (+1.35%)
At close: 04:00PM EDT
87.28 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
118,313
131,314
196,245
241,544
163,562
Cost of revenue
9,677
10,512
52,827
62,176
30,419
Gross profit
108,636
120,802
143,418
179,368
133,143
Operating expenses
Research development
23,845
24,537
36,082
32,105
40,503
Selling general and administrative
52,886
52,790
70,062
46,790
60,012
Total operating expenses
110,032
110,981
140,381
75,517
112,757
Operating income or loss
-1,396
9,821
3,037
103,851
20,386
Interest expense
557
656
1,799
19,619
27,415
Total other income/expenses net
115,228
46,784
32,727
-12,913
243
Income before tax
121,571
63,660
36,011
72,205
1,292
Income tax expense
25,227
9,841
41,230
-4,148
-5,306
Income from continuing operations
96,344
53,819
-5,219
76,353
6,598
Net income
96,344
52,154
-33,361
57,138
-2,985
Net income available to common shareholders
96,344
52,154
-33,361
57,138
-2,985
Basic EPS
0.93
3.02
-1.98
3.44
-0.18
Diluted EPS
0.87
2.94
-1.98
3.31
-0.18
Basic average shares
17,154
17,298
16,868
16,630
16,185
Diluted average shares
17,360
17,757
16,868
17,246
16,825